<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of an ABO-incompatible donor for BMT after total body irradiation (TBI) has no adverse effect on engraftment, incidence of GVHD or survival when donor erythrocytes and plasma are depleted from the infused marrow </plain></SENT>
<SENT sid="1" pm="."><plain>The outcome of ABO-incompatible BMT following a non-TBI-containing preparative regimen has not been as well studied </plain></SENT>
<SENT sid="2" pm="."><plain>We therefore performed a retrospective review of consecutive patients undergoing allogeneic BMT for myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> after treatment with high-dose <z:chebi fb="0" ids="28901">busulfan</z:chebi> and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (BUCY) between January 1984 and January 1993 </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 199 evaluable patients, 100 had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, 30 of which were ABO-incompatible, and 99 had <z:mp ids='MP_0005481'>CML</z:mp>, 35 of which were ABO-incompatible </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients undergoing transplant received erythrocyte and plasma-depleted marrow but 14 major ABO-incompatible patients also underwent plasma exchange before transplant </plain></SENT>
<SENT sid="5" pm="."><plain>T cell-<z:mpath ids='MPATH_63'>depletion</z:mpath> and purging techniques were not employed </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> records were reviewed for prognostic factors including patient age, sex, diagnosis, remission status at the time of transplant, and incidence and severity of <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD </plain></SENT>
<SENT sid="7" pm="."><plain>Compatible and incompatible patients with myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> did not differ with respect to age, sex, remission status of disease at the time of transplant or incidence of GVHD.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>